Phase 3 Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people joining from a previous related study (long-term follow-up participants):
- You are at least 1 month old and have a confirmed diagnosis of epilepsy, and previously took part in one of two specific earlier studies (NCT01364597 or NCT03325439)
For people in Japan joining the study directly (not from a previous study):
- You are between 4 and 15 years old
- You have had a brain wave test (EEG) in the last 10 years that is consistent with a type of epilepsy that starts in one part of the brain (focal epilepsy)
- Your seizures have not been fully controlled even after trying at least one epilepsy medication properly
- You had at least one seizure during the 4-week check-in period before the study begins
Who may not be able to join:
For all participants:
- You have a serious medical, neurological, or psychiatric condition, or abnormal test results, that could affect your safety in the study
- You are currently taking part in another study involving an experimental medication or medical device (other than the drug brivaracetam, which this study uses)
For people joining from a previous related study only:
- If you are 6 years old or older, you have ever attempted suicide in your lifetime, or have had thoughts of suicide in the past 6 months (as measured by a specific rating scale)
For people in Japan joining the study directly only:
- You have a history of a type of epilepsy that affects the whole brain at once, seizures caused by psychological factors, or seizures caused by fever
- You had a prolonged or severe seizure episode in the 30 days before your screening visit or during the screening period
- You have any significant illness that could affect the study (confirm with trial site)
- You have abnormal blood or lab test results that could increase risks or affect the study results
- You have a significant abnormality on a heart electrical test (ECG)
- You had major surgery within 6 months before the start of the screening visit
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: UCB Cares, 001 844 599 2273 (UCB)
Phone: 0018445992273
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of treatment-emergent adverse events (TEAEs) during the study; Incidence of treatment-emergent serious adverse events (SAEs) during the study; Incidence of treatment-emergent adverse events (TEAEs) leading to discontinuation of study drug during the study
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.